Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANVS - Annovis Bio, Inc.
17.3 M
LAST VALUE
-39.09%
2 YEAR CAGR
134.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR